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Summary
The HLA-A2-positive human mutant cell line T2 is not lysed by influenza virus-specific HLA
A2-restricted cytotoxic lymphocytes after virus infection . However, lysis does occur when cells
are incubated with the antigenic influenza matrix protein-derived peptide M57-68 . To examine
the nature of this defect, T2 cells were transfected with two different plasmids . One plasmid
encoded the peptide M57-68, and the other encoded the same peptide preceded by an endoplasmic
reticulum translocation signal sequence. MutantT2 cells expressing the M57-68 peptide without
the signal sequence were not susceptible to lysisby M57-68-specific HLAA2-restricted cytotoxic
T lymphocytes, whereas T2 cells expressing the M57-68 peptide plus signal sequence were lysed
effectively . Lysis of parental T1 cells with either plasmid was equally effective . These results suggest
that the T2 mutant cells are defective in the transport of antigenic peptides from the cytosol
into the secretory pathway.
T
hree mutant cell lines (RMA-S, .174, and T2) have been
described that are not lysed by class I-restricted CTL
after virus infection but are lysed after exposure to synthetic
peptides corresponding to antigenic determinants of the viral
proteins (1-3) . Furthermore, these mutants synthesize class
I heavy chains, but the majority of detectable heavy chain
remains intracellular and associates poorly with (32-
microglobulin (1, 4, 5) .
The mouse cell line RMA-S was derived by EMS muta-
genesis and selection for loss of H-2 expression (6) . Thehuman
cell line .174 with a homozygous deletion of the class II re-
gion of theMHC fails to expressHLAB5 and expresses HLA
A2 at reduced levels (20-30% ; reference 7) . A hybrid cell
line, T1, produced by fusing .174 cells to T lymphoblastoid
cells (CEM), phenotypically resembles wild-type cells : high
levels ofHLAA2 and -B5 are expressed and whole antigens
as well as peptide are processed and presented in the context
of HLA-A2 (1, 5) . A derivative cell line (T2) without the
two intact copies ofchromosome 6 derived from CEM cells
is similar to .174 with low or absent expression of HLAA2
and -B5, and it fails to process and present antigen after virus
infection (1, 5, 8) . These observations suggest that a trans-
acting factor encoded by a gene in the MHC controls the
mutant phenotype.
The defect in the mutant cell lines may involve antigen
processing, transport of antigen or antigen-derived peptides
from the cytoplasm to a class I containing compartment, or
the intracellular association of peptides with class I mole-
cules and their subsequent transport to the cell surface. A
defective antigen or peptide transport mechanism was origi-
nally proposed byTownsend and coworkers (1, 2) to explain
the functional deficiencies of the mutant cell lines and the
ability to correct them by supplying exogenous peptides. The
recent finding that genes with sequences related to ATP-
dependent transport proteins are present in the region of the
MHC deleted in .174 and T2 (9-12) is consistent with this
mechanism . To investigate this possibility experimentally, ex-
pression vectors encoding the influenza matrix peptide M57-
68 with or without an endoplasmic reticulum translocation
signal sequence were transfected into T2 cells, and presenta-
tion of that peptide to human CTL in the context of HLA-
A2 was examined .
Materials and Methods
Cell Lines .
￿
The derivation of the cell lines C1R, T1, and T2
are described elsewhere (13). C1R:A2 isCIR that expresses a trans-
fected genomic clone ofHLA-A2.1 (14) . CIR, ClRA2, T1, and
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Island, NY) or RPMI 1640 with 10% FCS (IMDM/FCS,
RPMI/FCS) and 20 lAg/ml gentamicin.
CTL lines specific for the influenza virus typeA matrix peptide
57-68 (M57-68) were generated essentially as described (14), using
2 U/ml rI1r2 (Amgen Biologicals, Thousand Oaks, CA) and
peptide-pulsed PBMC as stimulators .
Construction ofEpisomal Vectors.
￿
The expression plasmids p8901-
Ml and p8901-SM1 were constructed by ligation of oligonucleo-
tide duplexes, coding for the appropriate amino acid residues, into
the unique BamHI site ofp8901 (kindly provided by Dr. G.E . Mark,
Merck Sharp and Dohme Research Laboratories) . Plasmid p8901-
Ml encodes a peptide ofthe influenza virus matrix protein (residues
57-68 ; M57-68), and plasmid p8901-SM1 encodes peptide M57-68
preceded by the adenovirus E3/19-kD protein signal sequence (15),
as shown in Fig. 1 .
Transfection ofEpisomal Minigene Expression Vectors.
￿
CIR and
C1R:A2 cells were electroporated at 230 mV, 960 FFarads, and TI
and T2 cells at 210mV, 500,uFarads, with 20,ugDNA as described
(13) . 24 h after electroporation, cells were resuspended in 24 ml
selective (hygromycin-containing) medium (Boehringer Mannheim
Biochemicals, Indianapolis, IN ; 300 wg/ml for CIR, 450 Icg/ml
for TI and T2 cells) and plated at 1 ml/well in 24-well plate. Three
plasmids, referred to as p8901 (control plasmid without insert),
p8901-Ml (with peptide M57-68 minigene), and p8901-SM1(M57-
68 minigene plus signal sequence), were Tansfected into C1R,
CIR:A2, T1, and T2 cells. Transfected cells will be referred to as
CIR(p8901), CIR(MI), ClR(SM1), etc.
Results
Intracellular Expression of a Peptide with a Leader Sequence
Renders T2 Cells Sensitive to Lysis by HLAA2-restricted CTL .
Cytotoxic assays were performed with TansfctedC1R, T1,
and T2 cells using HLAA2-restricted CTL specific for ma-
trix peptide M57-68 (Fig. 2) . Cells with control plasmid p8901
(Fig. 2, A-C) were not susceptible to lysis and HLAA2-
negative ClR(Ml) and CIR(SMI) cells were not lysed ei-
ther (Fig . 2 A) . Both TI(Ml) and Tl(SM1) cells were lysed
with equal efficiency (Fig. 2 B) ; similar results (data not shown)
were obtained with wild-type ClR:A2(Ml) and CIR:A2
(SMI) cells . Mutant T2(M1) cells were lysed poorly in con-
trast to T2(SM1) cells, which were very susceptible to lysis
(Fig . 2 C) .
In this particular experiment, lysis of T2(p8901), T2(M1)
and T2(SMl) was 3, 11, and 62%, respectively, at an E/T
ratio of 5 . Six additional experiments were carried out with
these cells using CTL from two donors . Average lysis (E/T
= 5) was 3 (T2[p8901]), 14 (T2[Ml]) and 64% (T2[SMl]) ;
lysis ofT1 cells in four experiments was 14 (T1[p8901]), 53
(T1[Ml]), and 42% (T1[SM1]) . Additional control experi-
ments established that all HLAA2-positive cells that were
not lysed in the experiments described above (i .e., Tl[p8901],
T2[p8901], and T2[M1]) were susceptible to lysis when as-
sayed in the presence of 1 p,M synthetic peptide M57-68
(45-75% at E/T = 5).
ExtracellularAssociation ofPlasmid-encoded Peptide with HLA-
A2 Was Not Detectable The most likely explanation for these
results is that peptide M57-68, after synthesis in the cytoplasm,
is translocated into the endoplasmic reticulum in T1 and wild-
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￿
Episomal expression vectors. To constrict theinserts forp8901-
Ml, the following oligonucleotides were annealed, extended with Klenow
and dNTPs, and amplified byPCR : 5'-ATAGGATCCCCACCATGAAA-
GGTATTCTCGGCTTCGTCTCC-3' and 3'-GAGCCGAAGCAGAAG-
TGGGAATGACAGACTCCATGGCGATCGCGC CGGCGTCTAGATAT
5'. The oligos for p8901-SM1 were 5'-ATAGGAT000CACCATGAGG-
TACATGATTTTAGGCTTGCTCGCCCTTGCGGCAGTCTGCAGCG-
CTGCCAAAGGTATTCTCGGCTTCGTCTTC-3' and 3=GAGCCGAA-
GCAGAAGTGGGAATGACAGACTCGCCGGCGTAT5. Note that the
oligos will construct a fragment containing BamHI (B), Nod (N), and
BgIII (Bg) restriction sites, and a Kozak consensus sequence (K) .
type CIR:A2 cells where it associates with HLAA2 mole-
cules . After transport to the cell surface, these complexes are
recognized by CTL (16-18) . In the mutant T2 cells, peptide
M57-68 is translocated very inefficiently but the defect is
reversed when the peptide also contains a signal sequence.
A potential alternative explanation for the results is that p8901-
SMl-derived peptides are translocated into the endoplasmic
reticulum, secreted into the medium, and subsequently as-
sociate with HLAA2 molecules at the cell surface.
Table 1 shows that such extracellular sensitization cannot
be detected . T2(p8901) cells were cocultivated with CIR(SM1)
cells such that both cell types were present after 7 d in equal
amounts as judged by FACS6 analysis with the HLAA2-
specificmAb MA2.1. Peptide M57-68, if secreted in significant
amounts by HLAA2-negative ClR(SM1) cells, should have
sensitized bystander HLAA2-positive T2(p8901) cells . How-
ever, lysis was not observed . Additional experiments (data
not shown) established that the addition of supernatants of
ClR(SM1), Tl(SM1), and T2(SM1) cells to Tl(p8901) and
T2(p8901) cells did not render the latter susceptible to lysis.
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HLA-A2-positiveT2(p8901) cells were mixed with HLA-A2-negative
ClR(SM1) cells at a ratio of70-30% . After 1 wk of cocultivation, both
cell types were present at equal amounts as judged by FACS® analysis
using mAb MA2 .1 . This mixed culture as well as control cells were la-
beled with s1Cr, and susceptibility to lysis by M57-68-specific CTL was
determined at an E/T ratio of 5 in the presence and absence of synthetic
peptide M57-68 .
At 1 uM .
Discussion
Their mutant antigen processing phenotype raises the pos-
sibility that T2 cells are deficient in peptide transport from
the cytoplasm into the endoplasmic reticulum (1, 2) . Conse-
quently, complexes of class I molecules and peptides are not
formed and expressed on the cell surface. If this were the case,
then one should be able to reverse the mutant phenotype by
using an alternative peptide transport pathway.
The results described in this paper showed that this reversal
can be achieved . Both wild-type T1 and mutantT2 cells were
transfected with expression plasmids containing minigenes
We thank Dr. Maria Bednarek from the Merck Sharp and Dohme Research Laboratories for providing
us with peptide M57-68 .
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Figure 2 .
￿
Lysis of minigene transfec-
tants by HLA-A2-restricted M57-68-
specific CTL . Target cells were labeled
overnight with s1Cr, and effectors were
added at varying ratios in standard 4-h
cytolytic assays (14) . (A)MR transfec-
tants; (B) T1 transfectants; (C) T2 trans-
fectants. (O) Cells with plasmid p8901;
(" ) with p8901-M1; (0) with
p8901-SM1 .
coding for the influenza virus matrix protein-derived pep-
tide M57-68 with or without an NH2-terminal signal se-
quence . Peptides with the signal sequence should cross the
endoplasmic reticulum membrane by the normal signal rec-
ognition particle (SRP)-dependent translocation pathway (16) .
We observed that the addition of a leader sequence to the
minigene-encoded matrix peptide dramatically improved rec-
ognition of T2 cells by HLA-A2-restricted M57-68-specific
CTL . In contrast, T1 and wild-type ClR:A2 cells presented
both minigene products equally well . These results are con-
sistent with the hypothesis that T2 lacks the ability to trans-
locate peptides across a membrane by an SRP-independent
mechanism, the physiological mechanism used by wild-type
cells. Our results add weight to the proposal that the puta-
tive ATP-dependent transport proteins that map to theMHC
could provide the physiological step missing inT2 cells (9-12) .
RMA-S, .174, and T2 were initially identified because of
the shared phenotype oflow surface expression ofclass I mol-
ecules . This low expression is believed to reflect either im-
paired transport (2) or reduced stability (17) of class I heavy
chain R2-microglobulin dimers that lack associated peptides .
The addition of synthetic peptides to these cells increased
class I cell surface expression (1, 2) . Therefore, we examined
the transport and surface expression ofHLAA2 heavy chain
(32-microglobulin dimers in the minigene transfectants by 3'S
methionine pulse-chase experiments and FACS® analysis (see
references 1 and 2) . No differences were observed in T2 cells
expressing either construct . One should note, however, that
since T cell-mediated lysis requires few peptides bound to
class I molecules at the cell surface (18, 19), peptide transport
into the endoplasmic reticulum and the expression ofHLA-
A2-peptide complexes could be sufficient for detection byCTL
but insufficient for detection by biochemical means .
.1 1
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Secretion
Mixed Cell Population
Cell type No p
T2(p8901) plusC1R(SM1) 4
T2(p8901) 4
C1R(SM1) 3
CIR:A2(p8901) 5
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